Regenacy Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Regenacy Pharmaceuticals they give services to treat diabetic and other peripheral neuropathies.
Regenacy Pharmaceuticals has raised $47.1M across 3 funding rounds on record, the most recent a Series B of $9.3M announced in Aug 2022.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Regenacy Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Aug 2022.
Regenacy Pharmaceuticals Funding Rounds
Regenacy Pharmaceuticals raised $30.0M in an undisclosed round announced in Mar 2020.
1.9 years later, a Series B of $7.8M was announced in Feb 2022.
6 months later, a Series B of $9.3M was announced in Aug 2022.
Regenacy Pharmaceuticals Founders and Leadership Team
Contact details for the Regenacy Pharmaceuticals team: 2 of 3 have an email address on file.
Start 14-day free trial →Regenacy Pharmaceuticals Funding Compared to Other Biotechnology Startups
Regenacy Pharmaceuticals' latest round of $9.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Regenacy Pharmaceuticals in Biotechnology and Waltham
Companies Similar to Regenacy Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Regenacy Pharmaceuticals Funding FAQs
What does Regenacy Pharmaceuticals do?
Regenacy Pharmaceuticals they give services to treat diabetic and other peripheral neuropathies.
How much funding has Regenacy Pharmaceuticals raised?
Regenacy Pharmaceuticals has raised $47.1M across 3 rounds on record. The most recent is a Series B of $9.3M announced in Aug 2022.
When did Regenacy Pharmaceuticals last raise funding?
Regenacy Pharmaceuticals' most recent funding round on record is a Series B of $9.3M, announced in Aug 2022.
Who is the CEO of Regenacy Pharmaceuticals?
Simon Jones is listed as CEO at Regenacy Pharmaceuticals.
Where is Regenacy Pharmaceuticals headquartered?
Regenacy Pharmaceuticals is based in Waltham, Massachusetts, United States.
How many employees does Regenacy Pharmaceuticals have?
Regenacy Pharmaceuticals is in the 11-50 employee band.
How does Regenacy Pharmaceuticals' funding compare to other Biotechnology startups?
Regenacy Pharmaceuticals' latest round of $9.3M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Regenacy Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Regenacy Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.